CompletedNot applicableNCT01428960

Study of Acute Effects of Sn-1 and Sn-3 Palmitic Acid-rich or Stearic Acid-rich Fats on Metabolic Markers

Studying Rapidly involuting congenital hemangioma

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Malaysia Palm Oil Board
Principal Investigator
Tony Ng
IMU University, Malaysia
Intervention
Palm Mid Fraction, Shea Butter, High Oleic Sunflower Oil(dietary_supplement)
Enrollment
36 target
Eligibility
20-50 years · All sexes
Timeline
20112013

Study locations (1)

Collaborators

IMU University, Malaysia

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01428960 on ClinicalTrials.gov

Other trials for Rapidly involuting congenital hemangioma

Additional recruiting or active studies for the same condition.

See all trials for Rapidly involuting congenital hemangioma

← Back to all trials